188 related articles for article (PubMed ID: 2789254)
21. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. I. Generation and recognition of virus strains and H-2b mutants.
Byrne JA; Ahmed R; Oldstone MB
J Immunol; 1984 Jul; 133(1):433-9. PubMed ID: 6202788
[TBL] [Abstract][Full Text] [Related]
22. Sensitivity of simian virus 40-transformed C57BL/6 mouse embryo fibroblasts to lysis by murine natural killer cells.
Fresa KL; Karjalainen HE; Tevethia SS
J Immunol; 1987 Feb; 138(4):1215-20. PubMed ID: 3027174
[TBL] [Abstract][Full Text] [Related]
23. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. II. Negative control by the Fv-1 locus in AKR mice of responder H-2b haplotype.
Green WR
J Immunol; 1984 May; 132(5):2665-71. PubMed ID: 6425410
[TBL] [Abstract][Full Text] [Related]
24. The lysis of cytotoxic T lymphocytes and their blasts by cytotoxic T lymphocytes.
Schick B; Berke G
Immunology; 1990 Nov; 71(3):428-33. PubMed ID: 2269479
[TBL] [Abstract][Full Text] [Related]
25. The signal-anchor domain of adenovirus E3-6.7K, a type III integral membrane protein, can direct adenovirus E3-gp19K, a type I integral membrane protein, into the membrane of the endoplasmic reticulum.
Wilson-Rawls J; Deutscher SL; Wold WS
Virology; 1994 May; 201(1):66-76. PubMed ID: 8178490
[TBL] [Abstract][Full Text] [Related]
26. Adenovirus E1A renders infected cells sensitive to cytolysis by tumor necrosis factor.
Duerksen-Hughes P; Wold WS; Gooding LR
J Immunol; 1989 Dec; 143(12):4193-200. PubMed ID: 2531778
[TBL] [Abstract][Full Text] [Related]
27. Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of blocking the lethal hit stage of CTL cytolysis and analysis of the cytolytic structure.
Hiserodt JC
J Immunol; 1985 Jul; 135(1):53-62. PubMed ID: 3158707
[TBL] [Abstract][Full Text] [Related]
28. CTL escape viral variants. I. Generation and molecular characterization.
Lewicki H; Tishon A; Borrow P; Evans CF; Gairin JE; Hahn KM; Jewell DA; Wilson IA; Oldstone MB
Virology; 1995 Jun; 210(1):29-40. PubMed ID: 7793078
[TBL] [Abstract][Full Text] [Related]
29. Relative immunogenicity of hepatitis B virus-encoded antigens as targets for cytotoxic T-cell response.
Ishikawa T; Kakumu S; Yoshioka K; Yamada M; Tanaka K; Higashi Y; Takayanagi M; Okumura A; Kojima A; Tamura T
Immunology; 1993 Oct; 80(2):313-8. PubMed ID: 8262560
[TBL] [Abstract][Full Text] [Related]
30. Deletion mutation analysis of the adenovirus type 2 E3-gp19K protein: identification of sequences within the endoplasmic reticulum lumenal domain that are required for class I antigen binding and protection from adenovirus-specific cytotoxic T lymphocytes.
Hermiston TW; Tripp RA; Sparer T; Gooding LR; Wold WS
J Virol; 1993 Sep; 67(9):5289-98. PubMed ID: 8350398
[TBL] [Abstract][Full Text] [Related]
31. Cell-mediated lympholytic responses against autologous cells modified with haptenic sulfhydryl reagents. V. H-2Ld self products are recognized by anti-AED-specific cytotoxic T cells.
Levy RB; Shearer GM
J Immunol; 1983 Apr; 130(4):1506-11. PubMed ID: 6187809
[TBL] [Abstract][Full Text] [Related]
32. The adenovirus E3-14.7K protein is a general inhibitor of tumor necrosis factor-mediated cytolysis.
Gooding LR; Sofola IO; Tollefson AE; Duerksen-Hughes P; Wold WS
J Immunol; 1990 Nov; 145(9):3080-6. PubMed ID: 2145367
[TBL] [Abstract][Full Text] [Related]
33. Expression of CTL-defined, AKR/Gross retrovirus-associated tumor antigens by normal spleen cells: control by Fv-1, H-2, and proviral genes and effect on antiviral CTL generation.
Green WR
J Immunol; 1986 Jan; 136(1):308-12. PubMed ID: 2999246
[TBL] [Abstract][Full Text] [Related]
34. Stabilization of transgene expression by incorporation of E3 region genes into an adenoviral factor IX vector and by transient anti-CD4 treatment of the host.
Poller W; Schneider-Rasp S; Liebert U; Merklein F; Thalheimer P; Haack A; Schwaab R; Schmitt C; Brackmann HH
Gene Ther; 1996 Jun; 3(6):521-30. PubMed ID: 8789802
[TBL] [Abstract][Full Text] [Related]
35. Lysis of target cells infected with vesicular stomatitis virus (VSV) in the presence of tunicamycin by anti-VSV cytotoxic T lymphocytes.
Harris DT; Hale AH; Lefrancois L
J Immunol; 1981 May; 126(5):1914-8. PubMed ID: 6260860
[TBL] [Abstract][Full Text] [Related]
36. The signal sequence of lymphocytic choriomeningitis virus contains an immunodominant cytotoxic T cell epitope that is restricted by both H-2D(b) and H-2K(b) molecules.
Hudrisier D; Oldstone MB; Gairin JE
Virology; 1997 Jul; 234(1):62-73. PubMed ID: 9234947
[TBL] [Abstract][Full Text] [Related]
37. Immunization with soluble hepatitis B virus surface protein elicits murine H-2 class I-restricted CD8+ cytotoxic T lymphocyte responses in vivo.
Schirmbeck R; Melber K; Kuhröber A; Janowicz ZA; Reimann J
J Immunol; 1994 Feb; 152(3):1110-9. PubMed ID: 8301120
[TBL] [Abstract][Full Text] [Related]
38. Target determinants for F1 hybrid anti-parental H-2d cell-mediated lympholysis: self antigens controlled by the D end.
Nakamura I; Nakano K; Cudkowicz G
J Immunol; 1983 May; 130(5):2429-33. PubMed ID: 6187857
[TBL] [Abstract][Full Text] [Related]
39. Natural cytotoxicity against mouse hepatitis virus-infected target cells. I. Correlation of cytotoxicity with virus binding to leukocytes.
Holmes KV; Welsh RM; Haspel MV
J Immunol; 1986 Feb; 136(4):1446-53. PubMed ID: 3003198
[TBL] [Abstract][Full Text] [Related]
40. Poly(D,L-lactic-co-glycolic acid) microsphere delivery of adenovirus for vaccination.
Wang D; Molavi O; Lutsiak ME; Elamanchili P; Kwon GS; Samuel J
J Pharm Pharm Sci; 2007; 10(2):217-30. PubMed ID: 17706180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
